This scientific statement presents considerations for clinical management regarding the
assessment and risk reduction of select pediatric populations at high risk for premature …

Life expectancy and quality of life for those born with congenital heart disease (CHD) have
greatly improved over the past 3 decades. While representing a great advance for these …

Abstract Aims The New York Heart Association functional classification (NYHA class) is often
used to describe the functional capacity of adults with congenital heart disease (ACHD) …

The European project PHASE aims to evaluate patterns of change in the temperature–
mortality relationship and in the number of deaths attributable to heat in nine European cities …

Background Adults with congenital heart disease (CHD) have been considered potentially
high risk for novel coronavirus disease-19 (COVID-19) mortality or other complications …

Background Metabolic syndrome increases risk for atherosclerotic coronary artery disease,
and its prevalence increases with increasing age and body mass index. Adults with …

Background Progress in management of congenital heart disease has shifted mortality
largely to adulthood. However, adult survivors with complex congenital heart disease are not …

Background: Congenital heart defects (CHDs) occur in approximately 8 per 1000 live births.
Improvements in detection and treatment have increased survival. Few national estimates of …

Advances in surgical and clinical management of congenital heart disease (CHD) have
allowed patients to survive into adulthood. The number of adult congenital heart disease …

Background The number of patients with congenital heart disease (CHD) is increasing
worldwide and most of them will require cardiac surgery, once or more, during their lifetime …